2025 ESGO/ISSVD/ECSVD/EFC共识声明:宫颈癌筛查时的外阴检查

2025-01-30 欧洲妇科肿瘤学会 Int J Gynecol Cancer. 发表于上海

本文定义了正常外阴解剖的关键要素,识别潜在的癌前皮肤病,并强调了外阴恶性肿瘤的危险因素。

中文标题:

2025 ESGO/ISSVD/ECSVD/EFC共识声明:宫颈癌筛查时的外阴检查

英文标题:

Vulvar inspection at the time of cervical cancer screening: European Society of Gynaecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European Fed

发布机构:

欧洲妇科肿瘤学会

发布日期:

2025-01-30

简要介绍:

外阴鳞状细胞癌的发病率正在增加,特别是在60岁以下的妇女中,主要归因于人乳头瘤病毒感染。宫颈癌筛查期间的常规外阴检查可以提供检测外阴癌前病变的机会。本文定义了正常外阴解剖的关键要素,识别潜在的癌前皮肤病,并强调了外阴恶性肿瘤的危险因素。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2025 ESGO_ISSVD_ECSVD_EFC共识声明:宫颈癌筛查时的外阴检查.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1fa4f1c00a180e13, title=2025 ESGO/ISSVD/ECSVD/EFC共识声明:宫颈癌筛查时的外阴检查, enTitle=Vulvar inspection at the time of cervical cancer screening: European Society of Gynaecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European Fed, guiderFrom=Int J Gynecol Cancer., authorId=0, author=, summary=本文定义了正常外阴解剖的关键要素,识别潜在的癌前皮肤病,并强调了外阴恶性肿瘤的危险因素。, cover=https://img.medsci.cn/20250120/1737365815336_8538692.png, journalId=0, articlesId=null, associationId=1422, associationName=欧洲妇科肿瘤学会, associationIntro=, copyright=0, guiderPublishedTime=Thu Jan 30 00:00:00 CST 2025, originalUrl=, linkOutUrl=, content=<div class="guideDetailsCont flex-row-between-start" style="color: #333333;"> <div class="detailsContRight summary" style="color: #222222;" data-lines="12"> <p>外阴鳞状细胞癌的发病率正在增加,特别是在60岁以下的妇女中,主要归因于人乳头瘤病毒感染。宫颈癌筛查期间的常规外阴检查可以提供检测外阴癌前病变的机会。本文定义了正常外阴解剖的关键要素,识别潜在的癌前皮肤病,并强调了外阴恶性肿瘤的危险因素。</p> </div> </div>, tagList=[TagDto(tagId=1402, tagName=宫颈癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100)], articleKeywordId=1402, articleKeyword=宫颈癌, articleKeywordNum=6, guiderKeywordId=1402, guiderKeyword=宫颈癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1130, appHits=56, showAppHits=0, pcHits=124, showPcHits=1071, likes=0, shares=23, comments=3, approvalStatus=1, publishedTime=Mon Feb 10 20:25:00 CST 2025, publishedTimeString=2025-01-30, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Feb 10 15:29:10 CST 2025, updatedBy=8538692, updatedName=williamhill asia 话题小助手, updatedTime=Mon Feb 10 18:49:07 CST 2025, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2025 ESGO_ISSVD_ECSVD_EFC共识声明:宫颈癌筛查时的外阴检查.pdf)])
2025 ESGO_ISSVD_ECSVD_EFC共识声明:宫颈癌筛查时的外阴检查.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2251343, encodeId=4cbc225134316, content=宫颈癌筛查, beContent=null, objectType=guider, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2716443372, createdName=ms300, createdTime=Mon Feb 10 20:56:43 CST 2025, time=2025-02-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2251364, encodeId=4a2b22513641c, content=感谢您的分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/dc7b735700e1458a81dbbd2418ed68be-WBVuUZqXzOAb.jpg, createdBy=c6d55463285, createdName=Dew·, createdTime=Tue Feb 11 00:03:47 CST 2025, time=2025-02-11, status=1, ipAttribution=新疆)]
    2025-02-10 ms300 来自吉林省

    宫颈癌筛查

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2251343, encodeId=4cbc225134316, content=宫颈癌筛查, beContent=null, objectType=guider, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2716443372, createdName=ms300, createdTime=Mon Feb 10 20:56:43 CST 2025, time=2025-02-10, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2251364, encodeId=4a2b22513641c, content=感谢您的分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/dc7b735700e1458a81dbbd2418ed68be-WBVuUZqXzOAb.jpg, createdBy=c6d55463285, createdName=Dew·, createdTime=Tue Feb 11 00:03:47 CST 2025, time=2025-02-11, status=1, ipAttribution=新疆)]
    2025-02-11 Dew· 来自新疆

    感谢您的分享

    0

拓展阅读

Pediatric Blood Cancer:肿瘤康复儿童可以接种HPV疫苗吗?

研究显示,尽管建议9岁以上的女性儿童癌症幸存者(CCS)和造血干细胞移植(HSCT)受者接种 HPV 疫苗,但家长的接受度仍不明确。

超90%患者缓解!朱笕青团队带来宫颈癌一线治疗新方案

2 期试验显示,替雷利珠单抗联合低剂量贝伐珠单抗及标准化疗,治疗持续性、复发性或转移性宫颈癌,客观缓解率达 91.5%,中位无进展生存期 22.6 个月,安全性可控。

STTT:天津医科大学肿瘤医院刘文欣团队发表局晚期宫颈癌新辅助免疫化疗临床研究成果,pCR率达66.7%!

该研究展示了替雷利珠单抗联合化疗的新辅助治疗方案在IB3/IIA2期宫颈癌中显示出令人鼓舞的抗肿瘤活性、安全可控,这为局晚期宫颈癌(LACC)患者提供了一种新的治疗选择。

免疫重建良好,风险为何不减?新研究揭示HIV女性持续宫颈癌威胁

本研究旨在探讨在高效、依从性良好的现代ART治疗背景下,ART治疗时长和CD4+细胞计数是否会影响这种风险。

大咖谈 | 帕博利珠单抗助力局部晚期宫颈癌管理

2024年NMPA批准帕博利珠单抗联合CRT用于FIGO2014 III-IVA期患者,并获NCCN,CSCO等威廉亚洲博彩公司 推荐(1类证据),标志免疫治疗正式纳入LACC一线方案。

“绘”真报告 | 宫颈癌检出PALB2基因胚系突变,遗传和用药有何关键指引?

对一位宫颈癌患者基因检测发现 PALB2 基因胚系突变,研究显示宫颈癌存在遗传因素,PALB2 突变与多种癌种发病风险相关,PARP 抑制剂或可为相关宫颈癌治疗带来新希望。

2010 NACB医学实践威廉亚洲博彩公司 :肝癌、膀胱癌、子宫颈癌、胃癌肿瘤标志物的应用

美国临床生化科学院(NACB,The National Academy of Clinical Biochemistry) · 2010-01-01

2010ESMO临床实践威廉亚洲博彩公司 :宫颈癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-05-01

2010 宫颈癌规范化诊治威廉亚洲博彩公司

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2010-11-16

2011SOGC 低资源地区宫颈癌的预防

加拿大妇产科医生协会(SOGC,Society of Obstetricians and Gynaecologists of Canada) · 2011-03-01

2011 ESUR威廉亚洲博彩公司 :宫颈癌MRI分期

欧洲泌尿生殖放射学会(ESUR,European Society of Urogenital Radiology) · 2011-05-10

2011 子宫颈癌诊断威廉亚洲博彩公司

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2011-07-01